Report Feature
The future of the global protein delivery market looks promising with opportunities in the metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, and genetic disorders. The global protein delivery market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases and increasing awareness on high efficiency of protein therapeutics with the minimum risk of side effects.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein delivery market report, please download the report brochure.
In this market, monoclonal antibodies is the largest product of protein delivery, whereas metabolic disorders is the largest application. Growth in various segments of the protein delivery market are given below:
The study includes trends and forecast for the global protein delivery market by product, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Monoclonal Antibodies
- Insulin
- Fusion Protein
- Erythropoietin
- Interferon
- Human Growth Hormone
- Follicle Stimulating Hormone
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Metabolic Disorders
- Immunologic Disorders
- Hematological Disorders
- Cancer
- Hormonal Disorders
- Genetic Disorders
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the protein delivery companies profiled in this report include Abbott Laboratories, Amgen, Baxter International, Eli Lilly and Company, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co., Novo Nordisk, Pfizer, and Sanofi.
Lucintel forecasts that monoclonal antibodies will remain the largest segment over the forecast period as it is used in the treatment of different chronic disorders.
Within this market, metabolic disorders will remain the largest segment by application over the forecast period due to the introduction of patient support programs related to treatment of various metabolic disorders.
Asia-Pacific will remain the fastest growing region over the forecast period due to increasing awareness of people on protein therapeutic-based treatments and rising protein therapeutic applications.
|
Features of the Global Protein Delivery Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein delivery market by product monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, and follicle stimulating hormone), application (metabolic disorders, immunologic disorders, hematological disorders, cancer, hormonal disorders, genetic disorders, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein delivery market? Q.5 What are the business risks and threats to the global protein delivery market? Q.6 What are the emerging trends in this protein delivery market and the reasons behind them? Q.7 What are some changing demands of customers in this protein delivery market? Q.8 What are the new developments in this protein delivery market? Which companies are leading these developments? Q.9 Who are the major players in this protein delivery market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this protein delivery market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global protein delivery market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
4.1 Global Protein Delivery Market by Region
4.2.1 Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.2.2 Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.2.3 Market by Species: Fish, Crustaceans, and Mollusks
4.2.4 The United States Protein Delivery Market
4.2.5 The Canadian Protein Delivery Market
4.2.6 The Mexican Protein Delivery Market
4.3.1 Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.3.2 Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.3.3 The Protein Delivery Market of United Kingdom
4.3.4 The Spanish Protein Delivery Market
4.3.5 The German Protein Delivery Market
4.3.6 The French Protein Delivery Market
4.4.1 Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.4.2 Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.4.3 The Chinese Protein Delivery Market
4.4.4 The Indian Protein Delivery Market
4.4.5 The Japanese Protein Delivery Market
4.5.1 Market by Product: Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone
4.5.2 Market by Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others
4.5.3 Brazilian Protein Delivery Market
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
